Todd A Alonzo

7PUBLICATIONS
40CO-AUTHORS
Infant and child healthPaediatrics not elsewhere classifiedHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 31, 2024
Sociodemographic and Socioeconomic Factors Correlate with Late-Stage Pediatric Hodgkin Lymphoma and Rhabdomyosarcoma: A Report from the Children's Oncology Group Registries.

Judy Y Ou, Heydon K Kaddas, Todd A Alonzo

|May 27, 2024
EZH2-driven immune evasion at disease presentation defines a targetable high-risk subset of acute leukemia exemplified by t(16;21) FUS::ERG AML.

Nathaniel J Buteyn, Samantha J LaMantia, Connor G Burke

|Jan 10, 2024
DNA Damage Response Pharmacogenomic (DDR_PGx) Score Predicts Response to Chemotherapy Consisting of Gemtuzumab Ozogamicin in Pediatric AML: A Report from the Children's Oncology Group.

Vivek M Shastri, Lata Chauhan, Mohammed Gbadamosi

|Jul 15, 2022
IL-10 and TNFα are associated with decreased survival in low-risk pediatric acute myeloid leukemia; a children's oncology group report.

Alexandra M Stevens, Terzah M Horton, Chana L Glasser

Pageof 2